Healthcare / Medical Care FacilitiesBSE
$205.00
+3.10 (+1.54%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 20%
FCF escenarios
weak_data · normalized FCF $-157.8M · quality 52.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
56/100
C
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$4.0B
P/E
24.2x
↑EV/EBITDA
11.8x
↓ROE
17.1%
↑Gross Margin
77.6%
↑Debt/Equity
0.59
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+34.9%
FCF CAGR
—
FCF margin
0.1%
FCF / Net income
0.01x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.74B · net income $166.6M · FCF $1.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.74B | $1.74B | $1.22B | $844.0M | $707.0M |
| Net Income | $166.6M | $166.6M | $105.8M | $41.6M | $80.2M |
| EBITDA | $379.8M | $379.8M | $310.7M | $173.1M | $156.3M |
| EPS | — | — | 5.37 | 2.31 | 4.07 |
| Gross Margin | 77.6% | 77.6% | 77.1% | 73.3% | 71.7% |
| Operating Margin | 13.7% | 13.7% | 9.9% | 8.6% | 14.0% |
| Net Margin | 9.6% | 9.6% | 8.7% | 4.9% | 11.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.59 | 0.59 | 0.60 | 0.45 | 0.41 |
| Current Ratio | 1.45 | 1.45 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.9M | $1.9M | $-157.8M | $-200.0M | $-222.1M |
| Returns | |||||
| ROE | 17.1% | 17.1% | 13.1% | 5.9% | 19.2% |
| Valuation | |||||
| P/E | 24.17 | 24.17 | 15.08 | 37.08 | — |
| EV/EBITDA | 11.79 | 11.79 | 6.65 | 10.74 | — |
| P/B | 4.13 | 4.13 | 1.97 | 2.20 | — |
| Growth & Yield | |||||
| Revenue Growth | 42.5% | 42.5% | 44.3% | 19.4% | — |
| EPS Growth | — | — | 132.5% | -43.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+73.7%
Start / end P/E
n/dx → n/dx
EPS bridge
5.37 → n/d
Residual
+73.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.